Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Glenmark Pharma

Glenmark Pharma

BSE: 532296|NSE: GLENMARK|ISIN: INE935A01035|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 23, 15:03
581.00
8.65 (1.51%)
VOLUME 34,125
LIVE
NSE
Apr 23, 15:03
581.30
10.1 (1.77%)
VOLUME 480,140
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Glenmark Pharma

------------------- in Rs. Cr. -------------------
Dec '17 Sep '17 Jun '17 Mar '17 Dec '16
Net Sales/Income from operations 1,459.25 1,619.55 1,510.93 1,938.56 2,114.95
Other Operating Income 97.30 40.26 36.85 126.53 76.83
Total Income From Operations 1,556.55 1,659.81 1,547.78 2,065.09 2,191.78
EXPENDITURE
Consumption of Raw Materials 522.47 484.82 500.02 547.88 561.53
Purchase of Traded Goods 89.20 66.41 69.31 56.03 66.15
Increase/Decrease in Stocks -30.45 58.50 -10.93 0.10 7.30
Power & Fuel -- -- -- -- --
Employees Cost 255.40 326.43 207.77 221.13 227.41
Depreciation 29.55 28.89 29.94 27.32 26.34
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 453.14 326.20 428.68 567.85 484.99
P/L Before Other Inc. , Int., Excpt. Items & Tax 237.24 368.56 323.00 644.78 818.07
Other Income 37.23 56.30 42.59 -50.25 106.36
P/L Before Int., Excpt. Items & Tax 274.48 424.87 365.59 594.53 924.43
Interest 47.00 47.44 45.74 49.72 49.54
P/L Before Exceptional Items & Tax 227.48 377.43 319.85 544.81 874.89
Exceptional Items -- -- -- -236.45 --
P/L Before Tax 227.48 377.43 319.85 308.36 874.89
Tax 33.36 49.55 49.01 -48.70 163.58
P/L After Tax from Ordinary Activities 194.12 327.88 270.84 357.06 711.31
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 194.12 327.88 270.84 357.06 711.31
Equity Share Capital 28.22 28.22 28.22 28.22 28.22
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 6.88 11.62 9.60 12.65 25.21
Diluted EPS 6.88 11.62 9.60 12.65 25.20
EPS After Extra Ordinary
Basic EPS 6.88 11.62 9.60 12.65 25.21
Diluted EPS 6.88 11.62 9.60 12.65 25.20
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for glenmarkpharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.